Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-12 of 12 for your search:
Cancer Type/Condition:
T-cell childhood acute lymphoblastic leukemia
Stage/Subtype:
T-cell childhood acute lymphoblastic leukemia
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Study of Graft-Versus-Host Disease Prophylaxis Comprising Tacrolimus and Methotrexate With or Without Sirolimus in Pediatric Patients With Intermediate-Risk or High-Risk Acute Lymphoblastic Leukemia in Second Complete Remission Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Active
Age:
1 to under 22 at first relapse
Sponsor:
NCI
Protocol IDs:
COG-ASCT0431
, ASCT0431, COG-PBMTC-ONCO51, NCT00382109
2.
Phase III Randomized Study of Pegasparaginase Verus E. coli Asparaginase With Combination Chemotherapy in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
1 to 17
Sponsor:
NCI
Protocol IDs:
DFCI-05001
, NCT00400946
3.
Phase III Randomized Study of Augmented Berlin-Frankfurt-Münster-86 Multiagent Chemotherapy, Intensified Methotrexate, and Nelarabine in Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
1 to under 31
Sponsor:
NCI
Protocol IDs:
COG-AALL0434
, AALL0434, NCT00408005
4.
Phase III Partially Randomized Study of Risk-Directed Therapy Comprising a Modified P9407 Chemotherapy Backbone With or Without Lestaurtinib in Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase:
Phase III
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
1 and under at diagnosis
Sponsor:
NCI
Protocol IDs:
COG-AALL0631
, AALL0631, NCT00557193
5.
Phase I/II Pilot Study of Adoptive Immunotherapy With CD8+ WT1-Specific CTL Clones for Patients With Advanced Myelodysplastic Syndromes (MDS), Chronic Myelogenous Leukemia (CML), Acute Myeloid Leukemia (AML), or Acute Lymphoblastic Leukemia (ALL) After Allogeneic Hematopoietic Stem Cell Transplant
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
75 and under
Sponsor:
NCI
Protocol IDs:
FHCRC-1655.00
, 5430, NCT00052520
6.
Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
16 to 120
Sponsor:
Other
Protocol IDs:
090331
, NCT00983528
7.
Phase II Pilot Study of Bortezomib in Combination With Intensive Reinduction Chemotherapy in Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
1 to 31
Sponsor:
NCI
Protocol IDs:
COG-AALL07P1
, AALL07P1, NCT00873093
8.
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
8 to 75
Sponsor:
NHLBI
Protocol IDs:
090087
, 09-H-0087, NCT00859586
9.
Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
12 to 40
Sponsor:
Other
Protocol IDs:
2006-0375
, NCT00866749
10.
A Phase 1 Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
1 to 16
Sponsor:
Other
Protocol IDs:
20010133
, NCT00460421
11.
Pilot Study of Intensified Systemic Chemotherapy and Reduced-Dose Radiotherapy in Patients With Acute Lymphoblastic Leukemia and Late Isolated CNS or Testicular Relapse
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
18 months to 29 years at relapse
Sponsor:
NCI
Protocol IDs:
COG-AALL02P2
, AALL02P2, NCT00096135
12.
Randomized Study of Risk-Adjusted Therapies in Infants With Newly Diagnosed Acute Lymphoblastic or Biphenotypic Leukemia
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
365 days and under
Sponsor:
Other
Protocol IDs:
DCOG-INTERFANT-06
, DCOG-INTERFANT-06, EUDRACT-2005-004599-19, NCT00550992, CCLG-LK-2006-10
Select All on Page
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
